SOPs for COVID-19 Vaccines

Standard Operating Procedures to support the management of COVID-19 vaccines at vaccination clinics

Please refresh your webpage to see the most up to date information

• SOP - Guidance for management of Comirnaty (Pfizer/BioNTech) COVID-19 Vaccine from time of delivery at sites up to the time of administration.Version 1.0 3 February 2023
• SOP - Management of Spikevax® (previously COVID-19 Vaccine) Moderna and Spikevax bivalent Original/Omicron BA.1 (50 micrograms/50 micrograms)/ml dispersion for injection and Spikevax bivalent Original/Omicron BA.4-5 (50 micrograms/50 micrograms)/ml dispersion for injection –in 2.5ml vials Guidance Version 1.0 10 March 2023
• SOP - Management of JCOVDEN (JANSSEN COVID‐19) Vaccine Guidance at vaccination Clinics Version 6.0 8 August 2022
• SOP - Management of Nuvaxovid® (COVID-19 vaccine Novavax) Version 2.0 8 August 2022

If you require a copy of a reconciliation form please contact our office by email. Please include the setting and the vaccine type to help us to send you the correct form.

Please note if you are using TrackVax Vaccine Reconciliation should be done through this system instead.

Go back to COVID-19 Vaccine Information for Health Professionals

This page was added on 10 March 2023